Skip to main content
Premium Trial:

Request an Annual Quote

Ariadne Licenses PathwayStudio to Belgian Pharma UCB

NEW YORK, Jan. 11 (GenomeWeb News) - Ariadne Genomics has licensed its PathwayStudio software to UCB, a Belgian biopharmaceutical company, Ariadne said today.

 

UCB will use Pathway Studio for its research on nervous system disorders, allergy and respiratory diseases, immune and inflammatory disorders, and oncology, Ariadne said.

 

The PathwayStudio package comes with Ariadne's ResNet database of 500,000 functional relationships and MedScan modules for automatic extraction of information from scientific literature, the company said.

 

Financial details were not discussed.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.